Fennec Pharmaceuticals reported earnings of $ 0.12 per FENC share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | $ 0.096 |
| Earnings Per Share (Surprise) | $ 0.12 (+$ 0.024) |
| Last Year's EPS | -$ 0.08 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Fennec Pharmaceuticals beat analysts’ expectations 14 times and fell short of expectations 22 time(s). Fennec Pharmaceuticals reported earnings per share of $ 0.12 in the last report surpassing an estimated EPS of $ 0.096 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | $ 0.096 | $ 0.12 | -$ 0.02 | |
| Aug 11, 2026 | $ 0.02 | $ 0.05 | -$ 0.11 | |
| May 14, 2026 | -$ 0.02 | $ 0.01 | -$ 0.04 | |
| Mar 24, 2026 | $ 0.03 | -$ 0.17 | -$ 0.06 | |
| Nov 13, 2025 | -$ 0.08 | -$ 0.02 | -$ 0.21 | |
| Aug 14, 2025 | -$ 0.06 | -$ 0.11 | -$ 0.20 | |
| May 13, 2025 | -$ 0.12 | -$ 0.04 | $ 0.47 | |
| Mar 10, 2025 | $ 0.56 | -$ 0.06 | -$ 0.10 | |
| Nov 7, 2024 | -$ 0.13 | -$ 0.21 | -$ 0.07 | |
| Aug 13, 2024 | $ 0.06 | -$ 0.20 | -$ 0.21 | |
| May 14, 2024 | $ 0.26 | $ 0.47 | -$ 0.23 | |
| Mar 21, 2024 | -$ 0.02 | -$ 0.10 | -$ 0.26 | |
| Nov 6, 2023 | -$ 0.11 | -$ 0.07 | -$ 0.31 | |
| Aug 3, 2023 | -$ 0.18 | -$ 0.21 | -$ 0.19 | |
| May 11, 2023 | -$ 0.21 | -$ 0.23 | -$ 0.14 | |
| Mar 30, 2023 | -$ 0.24 | -$ 0.26 | -$ 0.18 | |
| Nov 11, 2022 | -$ 0.17 | -$ 0.31 | -$ 0.16 | |
| Aug 12, 2022 | -$ 0.10 | -$ 0.19 | -$ 0.15 | |
| May 12, 2022 | -$ 0.13 | -$ 0.14 | -$ 0.18 | |
| Feb 28, 2022 | $ 3.52 | -$ 0.18 | -$ 0.13 |
Fennec Pharmaceuticals’s stock was trading at $ 10.64 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, FENC’s price increased to $ 11.62 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | $ 0.12 | $ 10.64 | $ 11.62 | |
| Aug 11, 2026 | $ 0.05 | $ 10.94 | $ 11.83 | |
| May 14, 2026 | $ 0.01 | $ 6.77 | $ 9.75 | |
| Mar 24, 2026 | -$ 0.17 | $ 7.45 | $ 6.17 | |
| Nov 13, 2025 | -$ 0.02 | $ 7.78 | $ 7.86 | |
| Aug 14, 2025 | -$ 0.11 | $ 9.11 | $ 8.36 | |
| May 13, 2025 | -$ 0.04 | $ 6.27 | $ 6.33 | |
| Mar 10, 2025 | -$ 0.06 | $ 6.88 | $ 6.40 | |
| Nov 7, 2024 | -$ 0.21 | $ 4.95 | $ 4.29 | |
| Aug 13, 2024 | -$ 0.20 | $ 6.25 | $ 5.33 | |
| May 14, 2024 | $ 0.47 | $ 10.02 | $ 6.98 | |
| Mar 21, 2024 | -$ 0.10 | $ 11.07 | $ 10.80 | |
| Nov 6, 2023 | -$ 0.07 | $ 6.90 | $ 8.16 | |
| Aug 3, 2023 | -$ 0.21 | $ 8.64 | $ 8.03 | |
| May 11, 2023 | -$ 0.23 | $ 7.90 | $ 7.51 | |
| Mar 30, 2023 | -$ 0.26 | $ 8.32 | $ 8.32 | |
| Nov 11, 2022 | -$ 0.31 | $ 8.18 | $ 7.91 | |
| Aug 12, 2022 | -$ 0.19 | $ 7.05 | $ 6.79 | |
| May 12, 2022 | -$ 0.14 | $ 5.17 | $ 5.52 | |
| Feb 28, 2022 | -$ 0.18 | $ 5.43 | $ 5.56 |
Fennec Pharmaceuticals released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Fennec Pharmaceuticals beat analysts’ expectations during the last earnings period by
